Trial Profile
A Multi-center, Randomized, Double Blinding, Placebo-Controlled Clinical Trial of Dl-3-Butylphthalide in the Treatment of Amyotrophic Lateral Sclerosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2016
Price :
$35
*
At a glance
- Drugs Butylphthalide (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 03 May 2016 New trial record